Skip to content

UKGrowth Network

Companies Investors Regions Sectors

Home/Investors/TCGX

UK investor profile and portfolio

TCGX

1 UK company relationship(s) retained from funding evidence.

0 as lead

Open interactive record

UK portfolio companies

Beacon TherapeuticsLondon

Sources

https://www.prnewswire.com/news-releases/beacon-therapeutics-raises-170-million-in-series-b-funding-to-advance-development-of-ophthalmic-gene-therapies-302188599.html
https://www.massbio.org/members/beacon-therapeutics/

Public-source network refreshed 19 July 2026; the base funding and Companies House research is dated 18 July 2026. Candidate identities are not verified. Funding values are not audited transaction values.

Methodology and limitations